Related references
Note: Only part of the references are listed.Clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang et al.
CANCER LETTERS (2021)
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism
Valentina Tassinari et al.
GENOME BIOLOGY (2021)
The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation
Rui-Chao Chai et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
RNA modifications in brain tumorigenesis
Albert Z. Huang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Mechanism of RNA modification N6-methyladenosine in human cancer
Zijian Zhou et al.
MOLECULAR CANCER (2020)
m6A modification in RNA: biogenesis, functions and roles in gliomas
Yuhao Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
Yu-Zhou Chang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
m6A RNA Methylation Controls Neural Development and Is Involved in Human Diseases
Kunzhao Du et al.
MOLECULAR NEUROBIOLOGY (2019)
PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma
Zuoxin Zhang et al.
CANCER LETTERS (2019)
Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma
David J. Voce et al.
CANCER RESEARCH (2019)
Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma
Rui-Chao Chai et al.
CARCINOGENESIS (2019)
Genome-Wide CRISPR-Cas9 Screening Identifies NF-κB/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma
Kai Huang et al.
ADVANCED SCIENCE (2019)
N6-Methyladenosine Modulates Nonsense-Mediated mRNA Decay in Human Glioblastoma
Fuxi Li et al.
CANCER RESEARCH (2019)
IL-17 induces the proliferation and migration of glioma cells through the activation of PI3K/Akt1/NF-κB-p65
Bin Wang et al.
CANCER LETTERS (2019)
Integrated molecular characterization of IDH-mutant glioblastomas
A. Korshunov et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
Dan Jin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
A. Visvanathan et al.
ONCOGENE (2018)
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su et al.
CELL (2018)
Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
Ying Yang et al.
CELL RESEARCH (2018)
Multiple functions of m(6)A RNA methylation in cancer
Yutian Pan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway
Qixue Wang et al.
THERANOSTICS (2018)
Cross-talk among writers, readers, and erasers of m(6)A regulates cancer growth and progression
Subbarayalu Panneerdoss et al.
SCIENCE ADVANCES (2018)
Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2
Qun Chen et al.
CLINICAL CANCER RESEARCH (2018)
m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
Qi Cui et al.
CELL REPORTS (2017)
Roles of RNA methylation by means of N6-methyladenosine (m6A) in human cancers
Siwei Wang et al.
CANCER LETTERS (2017)
Dynamic RNA Modifications in Gene Expression Regulation
Ian A. Roundtree et al.
CELL (2017)
miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma
Fan Yang et al.
CANCER LETTERS (2017)
The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells
Kai Huang et al.
CANCER LETTERS (2017)
WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1
I. Vassallo et al.
ONCOGENE (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang et al.
CANCER LETTERS (2016)
N6-methyladenosine-encoded epitranscriptomics
Nian Liu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling
Y. Han et al.
CELL DEATH & DISEASE (2016)
N6-methyladenosine-encoded epitranscriptomics
Nian Liu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Fate by RNA methylation: m6A steers stem cell pluripotency
Boxuan Simen Zhao et al.
GENOME BIOLOGY (2015)
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang et al.
NATURE (2014)
Gene expression regulation mediated through reversible m6A RNA methylation
Ye Fu et al.
NATURE REVIEWS GENETICS (2014)
AQP5 is differentially regulated in astrocytes during metabolic and traumatic injuries
Rui Chao Chai et al.
GLIA (2013)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
Share Paper
